Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

854 Cr

Lock In Period

N/A

Expense Ratio

2.3

Benchmark

BSE Healthcare Total Return

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Summary

Latest details for Aditya Birla Sun Life Pharma & Healthcare Fund Growth include a 29.82 NAV as of Apr 02,2026 and returns since inception of 83.92%. Minimum investments start at SIP ₹100. The Aditya Birla Sun Life Pharma & Healthcare Fund Growth AUM is ₹854 Cr, with a lock-in of N/A years, expense ratio of 2.3%, and benchmark BSE Healthcare Total Return. Exit load is - For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.. In the growth review for 1M Month/Year, the fund recorded -3.62% returns, against a category average of -1.90% and a category best of -0.61%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-3.62-1.90-0.61
6M-1.760.618.52
1Y3.874.766.55
3Y22.5215.57102.23

Portfolio Analysis

  • Equity: 98.46%
  • Debt: 1.56%
  • Others
As on: 2026-02-28
View allocation % by

1. Sun Pharmaceutical Industries Limited13.34%
2. Torrent Pharmaceuticals Limited5.20%
3. J.B. Chemicals & Pharmaceuticals Limited4.99%
4. Ajanta Pharmaceuticals Limited4.53%
5. Lupin Limited4.21%
6. Aurobindo Pharma Limited4.16%
7. Abbott India Limited4.02%
8. IPCA Laboratories Limited3.94%
9. Cipla Limited3.59%
10. Emcure Pharmaceuticals Ltd3.03%
11. Mankind Pharma Ltd2.65%
12. Alkem Laboratories Limited2.31%
13. Shilpa Medicare Ltd2.20%
14. CORONA Remedies Ltd2.17%
15. SAI Life Sciences Ltd2.16%
16. Divi's Laboratories Limited1.95%
17. Dr. Reddys Laboratories Limited1.49%
18. Procter & Gamble Health Limited1.46%
19. ALEMBIC PHARMACEUTICALS LIMITED1.34%
20. Biocon Limited1.24%
21. Jubilant Pharmova Ltd1.19%
22. Pfizer Limited1.08%
23. Gland Pharma Limited1.07%
24. Piramal Pharma Ltd1.06%
25. GlaxoSmithKline Pharmaceuticals Limited0.99%

1. Apollo Hospitals Enterprise Limited7.78%
2. Fortis Healthcare Limited4.17%
3. Jupiter Life Line Hospitals Ltd1.94%
4. Thyrocare Technologies Limited1.63%
5. METROPOLIS HEALTHCARE LIMITED1.50%
6. Suraksha Diagnostic Ltd1.06%
7. Vijaya Diagnostic Centre Limited0.92%
8. Max Healthcare Institute Limited0.90%

1. SANOFI CONSUMER HEALTHCARE1.24%

1. Medi Assist Healthcare Services Ltd1.14%

About Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹854 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.3. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundTata India Pharma & HealthCare Fund Growth-0.761477.0844
This FundNippon India Pharma Fund Growth2.943480.3468
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth3.866183.9242
This FundSBI Healthcare Opportunities Fund Growth2.643591.148
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth2.539197.1567

FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.3. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -3.62%
  • 6 Months : -1.76%
  • 1 Year : 3.87%
  • 3 Years : 22.52%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 29.82 as on Apr 02,2026. Since inception, the return has been 83.92%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹854 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500